WT1 247-261 Peptide Vaccine

A synthetic peptide vaccine consisting of a HLA-DRw53-restricted human Wilms' Tumor protein-1 (WT1) peptide comprised of amino acids 247 through 261, a HLA class II-restricted WT1 peptide, with potential immunomodulating and antitumor activities. Vaccination with WT1 247-261 peptide may stimulate a CD4-positive helper T-lymphocyte-mediated immune response against WT1 expressing cells. Activated helper T-cells stimulate dendritic cells, and activate the proliferation of other T-lymphoctes and B-lymphocytes. This causes tumor cell lysis and inhibition of cancer cell proliferation in WT1-overexpressing tumor cells. WT1, a zinc finger DNA-binding protein, is overexpressed in most types of leukemia and in a variety of solid cancers. (NCI Thesaurus)

YOU MAY ALSO LIKE

WT1 235-243 Peptide Vaccine

A synthetic peptide vaccine consisting of a HLA-A24-restricted human Wilms' Tumor protein-1 (WT1) peptide comprised of amino acids 235 through 243, a…

WT1 126-134 Peptide Vaccine

A synthetic peptide vaccine consisting of the amino acids 126 through 134 of the human Wilms' Tumor protein-1 (WT1) with potential antitumor…

WT1 124-138 Peptide Vaccine

A synthetic peptide vaccine consisting of a HLA-DR15-restricted human Wilms' Tumor protein-1 (WT1) peptide comprised of amino acids 124 through 138, a…

WS

An inherited disorder marked by rapid aging that begins in early adolescence. Patients may be shorter than average, and have health problems…

WRNIP1 wt Allele

Human WRNIP1 wild-type allele is located in the vicinity of 6p25.2 and is approximately 21 kb in length. This allele, which encodes…

WRNIP1 Gene

This gene is involved in both ATP hydrolysis and DNA replication.